What to look for this week on Contemporary OB/GYN®
You can expect a variety of topics to be covered this week on Contemporary OB/GYN®, including:
In response to the coronavirus disease 2019 pandemic, many U.S. family planning providers have started offering telemedicine services.
In this video, Senior Editor Angie DeRosa interviews Emily Adhikari, MD, on questions or concerns she and colleagues are hearing from patients surrounding the COVID-19 vaccine.
A retrospective study in the journal Obstetrics & Gynecology and Reproductive Health has concluded that total laparoscopic retrograde hysterectomy (TLreH) for severe endometriosis with obliterated cul-de-sac is both feasible and safe.
Women with HIV are no more vulnerable to menopause-related cognitive declines compared to other women, according to a longitudinal cohort study in the journal Menopause.
Check back soon for additional updates.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More